Developer docs
API playgroundTry for free, no card

Search company profiles

Genomed

Full company profile

uuid000f1sw

Namestring
Genomed
Legal namestring
Genomed S.A.
Websiteurl
genomed.pl
Company typeenum
Public
Founded yearint
2008
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWarszawa, Poland
HQ citystring
Warszawa
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genetic diagnostics services, next generation sequencing, non-invasive prenatal testing, whole genome sequencing, clinical molecular diagnostics
Industry5 codes
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Genetic Diagnostics and NGS Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Genetic Testing Services (B2C)
TypeOne Time License
Description

Direct-to-patient genetic testing services through the NZOZ Genomed health centre including prenatal tests (SANCO, SANCO RHD, NIFTY), whole genome sequencing, whole exome sequencing, carrier screening (Parento), infant screening (INFANO), and disease-specific panels (oncology, cardiology, neurology, etc.). Tests are ordered online or in-person with genetic counselling included.

genomed.pl
2DNA Sequencing Services for Research (B2B)
TypeProfessional Services
Description

DNA sequencing, analysis, and synthesis services provided to over 200 scientific centres, biotechnology companies, and medical institutions. Includes NGS sequencing, bioinformatics analysis, de novo genome sequencing, exome sequencing, and metagenome analysis.

genomed.pl
3POLGENOM Database Licensing
TypeLicensing Royalties
Description

Commercial licensing of the Polish Reference Genome Database to research institutions, pharmaceutical companies, and clinical studies. The database is available at www.polgenom.pl.

diagnostyka.genomed.pl
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details8 tiers
1Whole Genome Sequencing with diagnostic analysis
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

12,500 PLN or 3,100 EUR. Includes interpretative analysis of pathogenic variants in 5,000 genes, pharmacogenomic variants, and nutrigenomic report with dietary recommendations.

genomed.pl
2SANCO Non-Invasive Prenatal Test
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

PLN 1,980 at NZOZ Genomed. Each clinic independently determines the test price. Payment installments available (MediRaty, up to 12 months).

diagnostyka.genomed.pl
3SANCO RHD Test - fetal RhD status assessment
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

350 PLN at NZOZ Genomed. Each clinic independently determines the test price.

diagnostyka.genomed.pl
4NIFTY Non-Invasive Prenatal Test
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

2,300 PLN at NZOZ Genomed. Available in 200 clinics across Poland. Results within 9 business days.

diagnostyka.genomed.pl
5INFANO - genetic screening test for infants
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

2,400 PLN (does not include optional MLPA testing). Includes over 70 diseases. Early intervention panel covers 141 genes and 78 diseases.

diagnostyka.genomed.pl
6Parento - carrier screening test for parents-to-be
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Parento OPTIMUM covers >85% hereditary genetic diseases; Parento MAXIMUM covers 1,700 genes detecting 95% of risk group couples.

diagnostyka.genomed.pl
7Silver-Russell Syndrome genetic test
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

990 PLN. MS-MLPA analysis of 11p15 locus methylation pattern and deletion/duplication identification. Turnaround time: up to 8 weeks.

diagnostyka.genomed.pl
8Clinical Exome and Clinical Exome MAXIMUM
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Clinical Exome MAXIMUM includes mitochondrial genome analysis. Highest quality analysis supported by POLGENOM Polish reference database.

diagnostyka.genomed.pl
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 5 records shown
1SANCO
Description

Non-invasive prenatal genetic test (NIPT) that analyzes cell-free fetal DNA from maternal blood to screen for chromosomal conditions including trisomy 21 (Down syndrome) and determines fetal RhD status.

diagnostyka.genomed.pl
+4 more records
Core offering1 text field

Genomed operates a genetic diagnostics and personalized medicine platform that delivers NGS-based tests (WGS, WES, NIPT), carrier and infant screening panels, and disease-specific genetic panels to individual patients through its NZOZ Genomed clinic and a ~300-clinic partner network. It separately provides B2B DNA sequencing, bioinformatics, and oligonucleotide synthesis services to over 200 scientific and biotech customers, and licenses the POLGENOM Polish population reference genome database to researchers and pharmaceutical firms. Revenue is generated from per-test diagnostic fees, professional sequencing service fees, and database licensing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • >99.5% test accuracy for the SANCO Non-Invasive Prenatal Test
+4 more records
Product overview1 text field

Genomed is a Polish genetic diagnostics company offering a comprehensive portfolio of genetic testing services centered on Next Generation Sequencing (NGS) technology. The core offerings include SANCO prenatal tests (non-invasive prenatal screening), Whole Exome Sequencing (WES), and Whole Genome Sequencing (GS) services. The product line spans preconception carrier screening (Parento), infant screening (INFANO), cancer predisposition testing (ONKO-MAX), and disease-specific tests. Supporting services include the Polgenom Polish Reference Genome Database for population-specific analysis and genetic counseling. The company operates as a single unified diagnostic service platform with multiple testing options and sub-brands for different market segments (clinical, research, personal genomics).

Product and service13 records
1SANCO Non-Invasive Prenatal Test
CategoryNon-Invasive Prenatal Testing (NIPT)
Description

Non-invasive prenatal genetic test (NIPT) that analyzes cell-free fetal DNA from maternal blood to screen for chromosomal conditions including trisomy 21 (Down syndrome), all 23 pairs of chromosomes, sex chromosomes, deletion and duplication syndromes from 7 Mbp, uniparental disomy risk, and early cancer detection. >99.5% accuracy with results in 5 business days.

2SANCO RHD Test
CategoryNon-Invasive Prenatal Testing (NIPT)
Description

Non-invasive prenatal test that determines fetal RhD status from maternal blood to guide immunoglobulin prophylaxis during pregnancy.

3NIFTY Non-Invasive Prenatal Test
CategoryNon-Invasive Prenatal Testing (NIPT)
Description

NIPT offered to pregnant women via NZOZ Genomed and partner clinics with 9-business-day turnaround.

4Clinical Whole Exome Sequencing (WES)
CategoryClinical Genome Sequencing
Description

Sequencing of protein-coding regions covering approximately 85% of genetic variants responsible for genetic diseases, with analysis of copy number variants (CNVs) and clinically relevant non-coding variants. Available as Clinical Exome or Clinical Exome MAXIMUM.

5Whole Genome Sequencing (WGS)
CategoryClinical Genome Sequencing
Description

Complete genome sequencing service with diagnostic analysis of over 5,000 genes associated with genetic disorders, including pharmacogenomic variants and nutrigenomic dietary recommendations.

6Parento Carrier Screening Test
CategoryReproductive / Carrier Genetic Screening
Description

Preconception carrier screening test for couples planning children, analyzing over 1,700 genes for more than 1,300 diseases including spinal muscular atrophy, cystic fibrosis, fragile X syndrome, and congenital adrenal hyperplasia, using NGS combined with MLPA and RFLP techniques.

7INFANO Genetic Screening for Infants
CategoryNewborn / Pediatric Genetic Screening
Description

Genetic screening test for infants and babies detecting over 70 diseases of genetic origin where prevention or therapy can halt development or prevent complications, covering metabolic, neurological, immunodeficiency, blood, eye, and ACMG-essential genes for childhood cancers and cardiovascular disorders.

8ONKO-MAX Cancer Predisposition Panel
CategoryOncology Genetic Testing
Description

Comprehensive cancer predisposition genetic test analyzing over 90 genes responsible for hereditary cancer, identifying pathogenic variants correlated with cancer risk and supporting personalised prevention plans.

9NGS Service Portfolio for Research & Biotech
CategoryResearch & Biotechnology Sequencing Services
Description

Next-Generation Sequencing services for research and biotech market including de novo sequencing of prokaryotic and eukaryotic genomes, exome sequencing, resequencing of genome fragments and amplicons, transcriptome sequencing, and metagenome sequencing and analysis (16S RNA, ITS).

10Oligonucleotide Synthesis Services
CategoryDNA Synthesis Services
Description

Oligonucleotide (DNA fragment) synthesis services for research laboratories and biotechnology customers.

11POLGENOM - Polish Reference Genome Database
CategoryGenomic Reference Database Licensing
Description

The only genomic database for the Polish population, unique internationally. Commercially licensed to research institutions, pharmaceutical companies, and clinical studies as a control group for population genetic studies and reference for genome analysis in diagnostics and personalised medicine.

12Genetic Counseling Service
CategoryClinical Genetic Counseling
Description

Clinical genetic counseling services provided by certified specialists for pre- and post-test consultation at NZOZ Genomed in Warsaw.

13DNA Sequence Analysis Services
CategoryBioinformatics & Sequence Analysis Services
Description

DNA sequence analysis and bioinformatics services provided to research and biotech customers.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1International Institute of Molecular and Cell Biology in Warsaw
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Consortium partner in the POLGENOM project 'Polish Reference Genome for Genomic Diagnostics and Personalised Medicine', co-financed by the Polish National Centre for Research and Development within the INNOTECH programme.

diagnostyka.genomed.pl
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Consortium partner in the POLGENOM project for creating the Polish Reference Genome Database.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Consortium partner in the POLGENOM project for creating the Polish Reference Genome Database.

4Instytut Matki i Dziecka (Institute of Mother and Child, Warsaw)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Genomed performed genetic testing for the national cystic fibrosis newborn screening programme on behalf of the institute from 2010-2012, approved by the Polish Ministry of Health. Active scientific cooperation with the institute's Department of Genetics.

genomed.pl
5Polsko-Japońska Wyższa Szkoła Technik Komputerowych (Polish-Japanese Academy of Information Technology)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

In October 2010, Genomed partnered with this institution and Centrum Onkologii to open the first interdisciplinary doctoral programme 'Bioinformatyka' in Poland, focused on personalised medicine and human genome analysis.

genomed.pl
6Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie w Gliwicach (Maria Skłodowska-Curie Oncology Centre – Institute, Gliwice)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in the interdisciplinary doctoral programme 'Bioinformatyka'. Scientific cooperation in population genetics projects.

genomed.pl
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Blood collection centre network. Venous blood samples from children under 10 can be collected at selected Diagnostyka network points based on a requisition issued by Genomed.

8European Molecular Quality Network (EMQN)
Strategic tierCoreTypeOthers
Description

Genomed participates in EMQN's external quality assessment schemes for genetic testing, achieving highest scores across multiple years and disease categories.

diagnostyka.genomed.pl
9Polish Society of Human Genetics - Network of Reference Laboratories
Strategic tierCoreTypeOthers
Description

NZOZ Genomed belongs to the Network of Reference Laboratories of the Polish Society of Human Genetics, covering diagnostics of over 20 genetic conditions.

diagnostyka.genomed.pl
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Established US clinical genetics company spanning hereditary cancer (BRCA), prenatal, pharmacogenomic, and mental health testing. Comparable as a broad incumbent across Genomed's hereditary cancer (ONKO-MAX), NIPT, and pharmacogenomic offerings, but with much wider geographic and portfolio reach.

TypeBroad incumbent
Description

European genomics services provider offering DNA sequencing, oligonucleotide synthesis, and bioinformatics to research and biotech customers. Highly comparable to Genomed's B2B sequencing and oligonucleotide synthesis arm serving 200+ scientific centres and biotech companies.

TypeDirect peer
Description

European clinical genetics and genomics laboratory focused on rare hereditary diseases and biomarker testing using NGS. Comparable to Genomed as a European specialty genetics lab combining WES/WGS diagnostics, carrier screening, prenatal testing, and reference-lab services to clinicians and pharma.

TypeDirect peer
Description

US-listed specialty genetics company best known for non-invasive prenatal testing (Panorama) and reproductive/oncology NGS panels. Closely comparable to Genomed on NIPT product (SANCO), reproductive carrier screening (Parento), and hereditary cancer panels (ONKO-MAX).

TypeRegional player
Description

Major private healthcare provider in Poland and CEE operating clinics, hospitals, and diagnostic services. Comparable as a regional private healthcare player overlapping with Genomed on clinical diagnostics and patient-facing genetic counselling pathways in Poland.

TypeEmerging player
Description

Asia-based genomics services company providing NGS sequencing, clinical diagnostics, and microarray services globally. Comparable to Genomed's B2B sequencing services portfolio (de novo sequencing, exome, metagenome) for research and clinical customers.

TypeBroad incumbent
Description

Europe's largest medical diagnostics services group with extensive clinical laboratory networks across CEE and Western Europe. Comparable to Genomed as a regional clinical laboratory operator, though Synlab is far broader (routine clinical chemistry, pathology) while Genomed focuses on advanced genetic testing.

TypeRegional player
Description

Poland's largest medical laboratory network, and a current sample-collection channel partner for Genomed. Comparable as a domestic Polish diagnostics provider with overlapping phlebotomy/sample collection infrastructure and overlapping clinical-laboratory services.

TypeBroad incumbent
Description

US-based clinical genetics testing company (now part of Labcorp) offering comprehensive hereditary disease, reproductive, and somatic NGS panels at scale. Comparable as a broad incumbent in clinical NGS diagnostics where Genomed competes on hereditary cancer and reproductive panels.

TypeDirect peer
Description

NGS-based clinical genetic diagnostics lab specializing in hereditary disease panels and rare-disease whole exome sequencing. Comparable to Genomed's Clinical WES, disease-specific panels, and reference-laboratory positioning for complex inherited disorders.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genomed

Clinical Genetic Diagnostics and NGS Servicesgenomed.pl

Genomed firmographics

Firmographics
Name
Genomed
Legal name
Genomed S.A.
Website
https://genomed.pl
Company type
Public
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Genomed industry classification

Industry
Product category
Clinical Genetic Diagnostics and NGS Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Keywords

  • Genetic diagnostics services
  • Next generation sequencing
  • Non-invasive prenatal testing
  • Whole genome sequencing
  • Clinical molecular diagnostics

Where Genomed is headquartered

Location

Headquarters

HQ city
Warszawa
HQ country
Poland
HQ region
Europe

Offices2 records

Markets served

Genomed business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Genetic Testing Services (B2C): Direct-to-patient genetic testing services through the NZOZ Genomed health centre including prenatal tests (SANCO, SANCO RHD, NIFTY), whole genome sequencing, whole exome sequencing, carrier screening (Parento), infant screening (INFANO), and disease-specific panels (oncology, cardiology, neurology, etc.). Tests are ordered online or in-person with genetic counselling included.
  2. DNA Sequencing Services for Research (B2B): DNA sequencing, analysis, and synthesis services provided to over 200 scientific centres, biotechnology companies, and medical institutions. Includes NGS sequencing, bioinformatics analysis, de novo genome sequencing, exome sequencing, and metagenome analysis.
  3. POLGENOM Database Licensing: Commercial licensing of the Polish Reference Genome Database to research institutions, pharmaceutical companies, and clinical studies. The database is available at www.polgenom.pl.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goWhole Genome Sequencing with diagnostic analysis
One time/ perpetual licensePay-as-you-goSANCO Non-Invasive Prenatal Test
One time/ perpetual licensePay-as-you-goSANCO RHD Test - fetal RhD status assessment
One time/ perpetual licensePay-as-you-goNIFTY Non-Invasive Prenatal Test
One time/ perpetual licensePay-as-you-goINFANO - genetic screening test for infants
Unit PricingPay-as-you-goParento - carrier screening test for parents-to-be
One time/ perpetual licensePay-as-you-goSilver-Russell Syndrome genetic test
One time/ perpetual licensePay-as-you-goClinical Exome and Clinical Exome MAXIMUM

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Genomed product offering

Product offering

Core offering

Genomed operates a genetic diagnostics and personalized medicine platform that delivers NGS-based tests (WGS, WES, NIPT), carrier and infant screening panels, and disease-specific genetic panels to individual patients through its NZOZ Genomed clinic and a ~300-clinic partner network. It separately provides B2B DNA sequencing, bioinformatics, and oligonucleotide synthesis services to over 200 scientific and biotech customers, and licenses the POLGENOM Polish population reference genome database to researchers and pharmaceutical firms. Revenue is generated from per-test diagnostic fees, professional sequencing service fees, and database licensing.

Product overview

Genomed is a Polish genetic diagnostics company offering a comprehensive portfolio of genetic testing services centered on Next Generation Sequencing (NGS) technology. The core offerings include SANCO prenatal tests (non-invasive prenatal screening), Whole Exome Sequencing (WES), and Whole Genome Sequencing (GS) services. The product line spans preconception carrier screening (Parento), infant screening (INFANO), cancer predisposition testing (ONKO-MAX), and disease-specific tests. Supporting services include the Polgenom Polish Reference Genome Database for population-specific analysis and genetic counseling. The company operates as a single unified diagnostic service platform with multiple testing options and sub-brands for different market segments (clinical, research, personal genomics).

Differentiator

Problem solved

Functional benefit

Brands

  • SANCO: Non-invasive prenatal genetic test (NIPT) that analyzes cell-free fetal DNA from maternal blood to screen for chromosomal conditions including trisomy 21 (Down syndrome) and determines fetal RhD status.
  • Polgenom
  • Parento
  • Infano
  • Clinical WES

Products and services

  • SANCO Non-Invasive Prenatal Test Non-invasive prenatal genetic test (NIPT) that analyzes cell-free fetal DNA from maternal blood to screen for chromosomal conditions including trisomy 21 (Down syndrome), all 23 pairs of chromosomes, sex chromosomes, deletion and duplication syndromes from 7 Mbp, uniparental disomy risk, and early cancer detection. >99.5% accuracy with results in 5 business days.
  • SANCO RHD Test Non-invasive prenatal test that determines fetal RhD status from maternal blood to guide immunoglobulin prophylaxis during pregnancy.
  • NIFTY Non-Invasive Prenatal Test NIPT offered to pregnant women via NZOZ Genomed and partner clinics with 9-business-day turnaround.
  • Clinical Whole Exome Sequencing (WES) Sequencing of protein-coding regions covering approximately 85% of genetic variants responsible for genetic diseases, with analysis of copy number variants (CNVs) and clinically relevant non-coding variants. Available as Clinical Exome or Clinical Exome MAXIMUM.
  • Whole Genome Sequencing (WGS) Complete genome sequencing service with diagnostic analysis of over 5,000 genes associated with genetic disorders, including pharmacogenomic variants and nutrigenomic dietary recommendations.
  • Parento Carrier Screening Test Preconception carrier screening test for couples planning children, analyzing over 1,700 genes for more than 1,300 diseases including spinal muscular atrophy, cystic fibrosis, fragile X syndrome, and congenital adrenal hyperplasia, using NGS combined with MLPA and RFLP techniques.
  • INFANO Genetic Screening for Infants Genetic screening test for infants and babies detecting over 70 diseases of genetic origin where prevention or therapy can halt development or prevent complications, covering metabolic, neurological, immunodeficiency, blood, eye, and ACMG-essential genes for childhood cancers and cardiovascular disorders.
  • ONKO-MAX Cancer Predisposition Panel Comprehensive cancer predisposition genetic test analyzing over 90 genes responsible for hereditary cancer, identifying pathogenic variants correlated with cancer risk and supporting personalised prevention plans.
  • NGS Service Portfolio for Research & Biotech Next-Generation Sequencing services for research and biotech market including de novo sequencing of prokaryotic and eukaryotic genomes, exome sequencing, resequencing of genome fragments and amplicons, transcriptome sequencing, and metagenome sequencing and analysis (16S RNA, ITS).
  • Oligonucleotide Synthesis Services Oligonucleotide (DNA fragment) synthesis services for research laboratories and biotechnology customers.
  • POLGENOM - Polish Reference Genome Database The only genomic database for the Polish population, unique internationally. Commercially licensed to research institutions, pharmaceutical companies, and clinical studies as a control group for population genetic studies and reference for genome analysis in diagnostics and personalised medicine.
  • Genetic Counseling Service Clinical genetic counseling services provided by certified specialists for pre- and post-test consultation at NZOZ Genomed in Warsaw.
  • DNA Sequence Analysis Services DNA sequence analysis and bioinformatics services provided to research and biotech customers.

Quantifiable outcome

  • >99.5% test accuracy for the SANCO Non-Invasive Prenatal Test
  • +4 more outcomes

Companies that use Genomed

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Genomed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Genomed partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • International Institute of Molecular and Cell Biology in WarsawcoreStrategic or Co-development PartnerConsortium partner in the POLGENOM project 'Polish Reference Genome for Genomic Diagnostics and Personalised Medicine', co-financed by the Polish National Centre for Research and Development within the INNOTECH programme.
  • Mossakowski Medical Research Centre of the Polish Academy of SciencecoreStrategic or Co-development PartnerConsortium partner in the POLGENOM project for creating the Polish Reference Genome Database.
  • 24godziny Sp. z o. o.coreStrategic or Co-development PartnerConsortium partner in the POLGENOM project for creating the Polish Reference Genome Database.
  • Instytut Matki i Dziecka (Institute of Mother and Child, Warsaw)coreStrategic or Co-development PartnerGenomed performed genetic testing for the national cystic fibrosis newborn screening programme on behalf of the institute from 2010-2012, approved by the Polish Ministry of Health. Active scientific cooperation with the institute's Department of Genetics.
  • Polsko-Japońska Wyższa Szkoła Technik Komputerowych (Polish-Japanese Academy of Information Technology)coreStrategic or Co-development PartnerIn October 2010, Genomed partnered with this institution and Centrum Onkologii to open the first interdisciplinary doctoral programme 'Bioinformatyka' in Poland, focused on personalised medicine and human genome analysis.
  • Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie w Gliwicach (Maria Skłodowska-Curie Oncology Centre – Institute, Gliwice)coreStrategic or Co-development PartnerPartner in the interdisciplinary doctoral programme 'Bioinformatyka'. Scientific cooperation in population genetics projects.
  • Diagnostyka SAminorChannel Partner/ Reseller/ DistributorBlood collection centre network. Venous blood samples from children under 10 can be collected at selected Diagnostyka network points based on a requisition issued by Genomed.
  • European Molecular Quality Network (EMQN)coreOthersGenomed participates in EMQN's external quality assessment schemes for genetic testing, achieving highest scores across multiple years and disease categories.
  • Polish Society of Human Genetics - Network of Reference LaboratoriescoreOthersNZOZ Genomed belongs to the Network of Reference Laboratories of the Polish Society of Human Genetics, covering diagnostics of over 20 genetic conditions.

Scale indicators10 records

Recent moves9 records

Expansion highlights5 records

Genomed competitors and assessment

Company assessment

Broad incumbents

  • Myriad Genetics: Established US clinical genetics company spanning hereditary cancer (BRCA), prenatal, pharmacogenomic, and mental health testing. Comparable as a broad incumbent across Genomed's hereditary cancer (ONKO-MAX), NIPT, and pharmacogenomic offerings, but with much wider geographic and portfolio reach.
  • Eurofins Genomics: European genomics services provider offering DNA sequencing, oligonucleotide synthesis, and bioinformatics to research and biotech customers. Highly comparable to Genomed's B2B sequencing and oligonucleotide synthesis arm serving 200+ scientific centres and biotech companies.
  • Synlab: Europe's largest medical diagnostics services group with extensive clinical laboratory networks across CEE and Western Europe. Comparable to Genomed as a regional clinical laboratory operator, though Synlab is far broader (routine clinical chemistry, pathology) while Genomed focuses on advanced genetic testing.
  • Invitae (Labcorp): US-based clinical genetics testing company (now part of Labcorp) offering comprehensive hereditary disease, reproductive, and somatic NGS panels at scale. Comparable as a broad incumbent in clinical NGS diagnostics where Genomed competes on hereditary cancer and reproductive panels.

Direct peers

  • Centogene: European clinical genetics and genomics laboratory focused on rare hereditary diseases and biomarker testing using NGS. Comparable to Genomed as a European specialty genetics lab combining WES/WGS diagnostics, carrier screening, prenatal testing, and reference-lab services to clinicians and pharma.
  • Natera: US-listed specialty genetics company best known for non-invasive prenatal testing (Panorama) and reproductive/oncology NGS panels. Closely comparable to Genomed on NIPT product (SANCO), reproductive carrier screening (Parento), and hereditary cancer panels (ONKO-MAX).
  • Blueprint Genetics (Quest Diagnostics): NGS-based clinical genetic diagnostics lab specializing in hereditary disease panels and rare-disease whole exome sequencing. Comparable to Genomed's Clinical WES, disease-specific panels, and reference-laboratory positioning for complex inherited disorders.

Regional players

  • Medicover: Major private healthcare provider in Poland and CEE operating clinics, hospitals, and diagnostic services. Comparable as a regional private healthcare player overlapping with Genomed on clinical diagnostics and patient-facing genetic counselling pathways in Poland.
  • Diagnostyka SA: Poland's largest medical laboratory network, and a current sample-collection channel partner for Genomed. Comparable as a domestic Polish diagnostics provider with overlapping phlebotomy/sample collection infrastructure and overlapping clinical-laboratory services.

Emerging players

  • Macrogen: Asia-based genomics services company providing NGS sequencing, clinical diagnostics, and microarray services globally. Comparable to Genomed's B2B sequencing services portfolio (de novo sequencing, exome, metagenome) for research and clinical customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Genomed social profiles

Digital presence

Genomed compliance and trust

Trust signal

Compliance6 records

Genomed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genomed leadership team

Management profile

Number of profiles

Profiles2 records

Genomed funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genomed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genomed

What does Genomed do?

Genomed operates a genetic diagnostics and personalized medicine platform that delivers NGS-based tests (WGS, WES, NIPT), carrier and infant screening panels, and disease-specific genetic panels to individual patients through its NZOZ Genomed clinic and a ~300-clinic partner network. It separately provides B2B DNA sequencing, bioinformatics, and oligonucleotide synthesis services to over 200 scientific and biotech customers, and licenses the POLGENOM Polish population reference genome database to researchers and pharmaceutical firms. Revenue is generated from per-test diagnostic fees, professional sequencing service fees, and database licensing.

Is Genomed a public or private company?

Genomed is a public company. It is classified as public and is currently operating.

When was Genomed founded?

Genomed was founded in 2008. It employs 11 to 50 people.

Where is Genomed based?

Genomed is headquartered in Warszawa, Poland, in the Europe region.

How does Genomed make money?

Three revenue lines are on record. Genetic Testing Services (B2C) is the primary driver. The others are DNA Sequencing Services for Research (B2B) and POLGENOM Database Licensing.

Who are Genomed's main competitors?

Broad incumbents on record are Myriad Genetics, Eurofins Genomics, Synlab and Invitae (Labcorp). Direct peers are Centogene, Natera and Blueprint Genetics (Quest Diagnostics). Regional players are Medicover and Diagnostyka SA. Macrogen is listed as an emerging player.

Does Genomed have an API?

No public API is recorded for Genomed.

What industry is Genomed in?

Genomed's product category is Clinical Genetic Diagnostics and NGS Services. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals